Skip to main content

Cedars-Sinai Surgeons First in California to Acquire Synaptive Medical’s Technology

Cedars-Sinai Surgeons First in California to Acquire Synaptive Medical’s Technology

  • Cedars-Sinai Surgeons First in California to Acquire Synaptive Medical’s Technology

    BrightMatter™ provides precision in neurosurgical visualization and planning, surgical navigation and optics integration

    Cedars-Sinai announced on December 9, 2016 that they have completed the first brain surgery in California using Synaptive Medical’s BrightMatter™ technology. Cedars-Sinai is the first in the state to acquire this innovative system, which integrates imaging, surgical planning, and robotic visualization for neurosurgery.

    Surgeons such as Keith L. Black, MD, chair of the Cedars-Sinai Department of Neurosurgery and director of the Maxine Dunitz Neurosurgical Institute, hope to use BrightMatter Guide to better visualize important brain pathways in real time when entering the brain. “An estimated 62,000 primary brain tumors and 150,000 metastatic brain tumors are diagnosed annually in the U.S.,” said Dr. Black. “This new tool offers us a tremendous amount of hope for better outcomes for many of our patients.”

    In the video above, Dr. Black demonstrates how BrightMatter™ works and explains how it may help neurosurgeons to improve patient outcomes.

    “Cedars-Sinai is well known for their innovative, forward-thinking approach to neuroscience across the United States and abroad,” said Cameron Piron, president and co-founder of Synaptive Medical. “Our culture is built on connecting with neurosurgeons to better understand and address their challenges in the operating room and across the process of care. We look forward to many deep collaborations with Dr. Black and the team at Cedars to help facilitate better outcomes for patients.”

    Approximately 600 brain surgeries are performed each year at Cedars-Sinai. Their surgeons anticipate using Synaptive’s technology for a variety of neurosurgical cranial procedures. BrightMatter™ Drive and Vision are also cleared for use in spine cases.

    Click here to read the related Cedars-Sinai release.

    BACK TO NEWS ARTICLES